Search results
Results from the WOW.Com Content Network
Johnson & Johnson has twice been unsuccessful in using a controversial bankruptcy tactic to contain lawsuits alleging its baby powder caused cancer. The third time, J&J said, will be different.
A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an approximately $8 billion proposed settlement that would end tens of ...
The cancer victims sought a preliminary order in New Jersey on June 11 to preventing J&J from filing for bankruptcy outside the state, which would have effectively foiled the $6.48 billion ...
Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer ...
The case began in July 2023, when Michael Perry, a longtime user of Johnson & Johnson’s Baby Powder, was diagnosed with mesothelioma. Perry, used the powder daily due to an allergy to deodorants. His legal team argued that Johnson & Johnson had been aware of the asbestos contamination in its talc products since the 1970s but failed to warn ...
This is a list of Supreme Court of the United States cases in the area of bankruptcy. This list is a list solely of United States Supreme Court decisions about applying law related to bankruptcy. Not all Supreme Court decisions are ultimately influential and, as in other fields, not all important decisions are made at the Supreme Court level.
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.
J&J’s proposed settlement represents just 7.8% of its $85.2 billion in annual sales for 2023.